Brøsen K - Search Results

1

Impaired Glucose Tolerance in Healthy Men Treated with St. John's Wort.

Stage TB, Damkier P, Christensen MM, Nielsen LB, Højlund K, Brøsen K. Stage TB, et al. Among authors: brosen k. Basic Clin Pharmacol Toxicol. 2016 Mar;118(3):219-24. doi: 10.1111/bcpt.12486. Epub 2015 Oct 8. Basic Clin Pharmacol Toxicol. 2016. PMID: 26346185 Free article.

2

Effect of fluvoxamine on the pharmacokinetics of quinidine.

Damkier P, Hansen LL, Brøsen K. Damkier P, et al. Among authors: brosen k. Eur J Clin Pharmacol. 1999 Aug;55(6):451-6. doi: 10.1007/s002280050655. Eur J Clin Pharmacol. 1999. PMID: 10492058 Clinical Trial.

3

Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine.

Damkier P, Hansen LL, Brosen K. Damkier P, et al. Among authors: brosen k. Br J Clin Pharmacol. 1999 Dec;48(6):829-38. doi: 10.1046/j.1365-2125.1999.00099.x. Br J Clin Pharmacol. 1999. PMID: 10594487 Free PMC article.

4

Rifampicin treatment greatly increases the apparent oral clearance of quinidine.

Damkier P, Hansen LL, Brøsen K. Damkier P, et al. Among authors: brosen k. Pharmacol Toxicol. 1999 Dec;85(6):257-62. doi: 10.1111/j.1600-0773.1999.tb02019.x. Pharmacol Toxicol. 1999. PMID: 10628900 Clinical Trial.

5

Quinidine as a probe for CYP3A4 activity: intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6.

Damkier P, Brøsen K. Damkier P, et al. Among authors: brosen k. Clin Pharmacol Ther. 2000 Aug;68(2):199-209. doi: 10.1067/mcp.2000.108532. Clin Pharmacol Ther. 2000. PMID: 10976551 Clinical Trial.

6

Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide.

Bidstrup TB, Stilling N, Damkier P, Scharling B, Thomsen MS, Brøsen K. Bidstrup TB, et al. Among authors: brosen k. Eur J Clin Pharmacol. 2004 Apr;60(2):109-14. doi: 10.1007/s00228-004-0746-z. Epub 2004 Mar 19. Eur J Clin Pharmacol. 2004. PMID: 15034704 Clinical Trial.

7

Tramadol as a new probe for cytochrome P450 2D6 phenotyping: a population study.

Pedersen RS, Damkier P, Brosen K. Pedersen RS, et al. Among authors: brosen k. Clin Pharmacol Ther. 2005 Jun;77(6):458-67. doi: 10.1016/j.clpt.2005.01.014. Clin Pharmacol Ther. 2005. PMID: 15961977

8

Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.

Halling J, Petersen MS, Damkier P, Nielsen F, Grandjean P, Weihe P, Lundgren S, Lundblad MS, Brøsen K. Halling J, et al. Among authors: brosen k. Eur J Clin Pharmacol. 2005 Aug;61(7):491-7. doi: 10.1007/s00228-005-0938-1. Epub 2005 Jul 16. Eur J Clin Pharmacol. 2005. PMID: 16025294

9

Consumption of charcoal-broiled meat as an experimental tool for discerning CYP1A2-mediated drug metabolism in vivo.

Larsen JT, Brøsen K. Larsen JT, et al. Among authors: brosen k. Basic Clin Pharmacol Toxicol. 2005 Sep;97(3):141-8. doi: 10.1111/j.1742-7843.2005.pto_97365.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 16128907 Free article. Clinical Trial.

10

The impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinide.

Bidstrup TB, Damkier P, Olsen AK, Ekblom M, Karlsson A, Brøsen K. Bidstrup TB, et al. Among authors: brosen k. Br J Clin Pharmacol. 2006 Jan;61(1):49-57. doi: 10.1111/j.1365-2125.2005.02516.x. Br J Clin Pharmacol. 2006. PMID: 16390351 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters